In the 1966 film Fantastic Voyage, a spacecraft and its crew are shrunk to microscopic size and injected into the body of an injured astronaut to remove a life-threatening blood clot from his brain. The Academy Award-winning movie — later developed into a novel by Isaac Asimov — seemed like pure fantasy at the time. […]In the 1966 film Fantastic Voyage, a spacecraft and its crew are shrunk to microscopic size and injected into the body of an injured astronaut to remove a life-threatening blood clot from his brain. The Academy Award-winning movie — later developed into a novel by Isaac Asimov — seemed like pure fantasy at the time. […]

Internet of beings: The dream of digitizing human bodies for healthcare (and the nightmare)

In the 1966 film Fantastic Voyage, a spacecraft and its crew are shrunk to microscopic size and injected into the body of an injured astronaut to remove a life-threatening blood clot from his brain. The Academy Award-winning movie — later developed into a novel by Isaac Asimov — seemed like pure fantasy at the time. However, it anticipated what could be the next revolution in medicine: the idea that ever-smaller and more sophisticated sensors are about to enter our bodies, connecting human beings to the internet.

This “internet of beings” could be the third and ultimate phase of the internet’s evolution. After linking computers in the first phase and everyday objects in the second, global information systems would now connect directly to our organs. According to natural scientists, who recently met in Dubai for a conference titled Prototypes for Humanity, this scenario is becoming technically feasible. The impact on individuals, industries, and societies will be enormous.

The idea of digitizing human bodies inspires both dreams and nightmares. Some Silicon Valley billionaires fantasize about living forever, while security experts worry that the risks of hacking bodies dwarf current cybersecurity concerns. As I discuss in my forthcoming book, Internet of Beings, this technology will have at least three radical consequences.

First, permanent monitoring of health conditions will make it far easier to detect diseases before they develop. Treatment costs much more than prevention, but sophisticated tracking could replace many drugs with less invasive measures — changes in diet or more personalized exercise routines.

Millions of deaths could be prevented simply by sending alerts in time. In the US alone, 170,000 of the 805,000 heart attacks each year are “silent” because people don’t recognize the symptoms.

Second, the sensors — better called biorobots, since they’ll probably be made of gel — are becoming capable of not just monitoring the body but actively healing it. They could release doses of aspirin when detecting a blood clot, or activate vaccines when viruses attack.

The mRNA vaccines developed for COVID-19 may have opened this frontier. Advances in gene editing technologies may even lead to biorobots that can perform microsurgery with minuscule protein-made “scissors” that repair damaged DNA.

Third, and most important, medical research and drug discovery will be turned on its head. Today, scientists propose hypotheses about substances that might work against certain conditions, then test them through expensive, time-consuming trials. In the internet of beings era, the process reverses: huge databases generate patterns showing what works for a problem, and scientists work backwards to understand why. Solutions will be developed much more quickly, cheaply and precisely.

RADICAL TRANSFORMATIONS
The era of one-size-fits-all medicine is already ending, but the internet of beings will go much further. Each person could receive daily advice on medication doses tailored to micro-changes such as body temperature or sleep quality.

The organization of medical research itself will transform radically. Enormous amounts of data from bodies living natural lives might reveal that some headaches are caused by how we walk, or that brains and feet influence each other in unexpected ways.

Research currently focuses on specific diseases and organs. In future, this could shift to the use of increasingly sophisticated “digital twins” — virtual models of a person’s biology that update in real time using their health data. These simulations can be used to test treatments, predict how the body will respond, and explore disease before it appears. Such a shift would fundamentally change what we mean by life science.

The dream here isn’t to defeat ageing, as some transhumanists claim. It’s more concrete: making healthcare accessible to all Americans, saving the UK’s NHS, defeating cancers, reaching poorer countries, and helping everyone live longer without disease.

The nightmare, however, is about losing our humanity while digitizing our bodies. The internet of beings is one of the most fascinating possibilities that technology is opening up — but we need to explore it carefully. We’re resuming the voyage that humankind was travelling in those optimistic years of the 1960s, when we landed on an alien planet for the first time. Only now, the alien territory we’re exploring is ourselves.

THE CONVERSATION VIA REUTERS CONNECT

Francesco Grillo is an academic fellow at the Department of Social and Political Sciences of Bocconi University. This article was commissioned in conjunction with the Professors’ Program, part of Prototypes for Humanity, a global initiative that showcases and accelerates academic innovation to solve social and environmental challenges. The Conversation is the media partner of Prototypes for Humanity 2025. Mr. Grillo is director of Vision, The Think Tank.

Market Opportunity
Cyberlife Logo
Cyberlife Price(LIFE)
$0.0294
$0.0294$0.0294
-19.67%
USD
Cyberlife (LIFE) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Strive Finalizes Semler Deal, Expands Its Corporate Bitcoin Treasury

Strive Finalizes Semler Deal, Expands Its Corporate Bitcoin Treasury

Strive had finalized its acquisition of Semler scientific after securing the approval of shareholders earlier in the week. The final deal brought both firms’ Bitcoin
Share
Tronweekly2026/01/17 12:30
Why 2026 Is The Year That Caribbean Mixology Will Finally Get Its Time In The Sun

Why 2026 Is The Year That Caribbean Mixology Will Finally Get Its Time In The Sun

The post Why 2026 Is The Year That Caribbean Mixology Will Finally Get Its Time In The Sun appeared on BitcoinEthereumNews.com. San Juan, Puerto Rico’s La Factoría
Share
BitcoinEthereumNews2026/01/17 12:24
EUR/CHF slides as Euro struggles post-inflation data

EUR/CHF slides as Euro struggles post-inflation data

The post EUR/CHF slides as Euro struggles post-inflation data appeared on BitcoinEthereumNews.com. EUR/CHF weakens for a second straight session as the euro struggles to recover post-Eurozone inflation data. Eurozone core inflation steady at 2.3%, headline CPI eases to 2.0% in August. SNB maintains a flexible policy outlook ahead of its September 25 decision, with no immediate need for easing. The Euro (EUR) trades under pressure against the Swiss Franc (CHF) on Wednesday, with EUR/CHF extending losses for the second straight session as the common currency struggles to gain traction following Eurozone inflation data. At the time of writing, the cross is trading around 0.9320 during the American session. The latest inflation data from Eurostat showed that Eurozone price growth remained broadly stable in August, reinforcing the European Central Bank’s (ECB) cautious stance on monetary policy. The Core Harmonized Index of Consumer Prices (HICP), which excludes volatile items such as food and energy, rose 2.3% YoY, in line with both forecasts and the previous month’s reading. On a monthly basis, core inflation increased by 0.3%, unchanged from July, highlighting persistent underlying price pressures in the bloc. Meanwhile, headline inflation eased to 2.0% YoY in August, down from 2.1% in July and slightly below expectations. On a monthly basis, prices rose just 0.1%, missing forecasts for a 0.2% increase and decelerating from July’s 0.2% rise. The inflation release follows last week’s ECB policy decision, where the central bank kept all three key interest rates unchanged and signaled that policy is likely at its terminal level. While officials acknowledged progress in bringing inflation down, they reiterated a cautious, data-dependent approach going forward, emphasizing the need to maintain restrictive conditions for an extended period to ensure price stability. On the Swiss side, disinflation appears to be deepening. The Producer and Import Price Index dropped 0.6% in August, marking a sharp 1.8% annual decline. Broader inflation remains…
Share
BitcoinEthereumNews2025/09/18 03:08